Pro-inflammatory signaling pathways and downstream cytokines

Pro-inflammatory signaling pathways and downstream cytokines constitute the biochemical network responsible for orchestrating the body's immune and inflammatory responses. This system involves the activation of intracellular cascades, such as the NF-κB, MAPK, and JAK-STAT pathways, in response to stimuli like pathogens or tissue damage (Hayden, M. S., & Ghosh, S., 2008, Cell). These pathways lead to the expression and secretion of various cytokines, including Tumor Necrosis Factor-alpha (TNF-α), Interleukin-1 (IL-1), and Interleukin-6 (IL-6), which act as messengers to recruit and activate immune cells (Dinarello, C. A., 2000, Chest). Dysregulation of these pathways is central to the pathogenesis of chronic inflammatory diseases, autoimmune disorders, and "cytokine storms" seen in severe infections (O'Shea, J. J., & Plenge, R., 2012, Nature). Pharmacological targeting of this system includes the use of monoclonal antibodies to neutralize specific cytokines or small molecule inhibitors to block signaling enzymes like Janus kinases (JAKs). While effective in treating conditions like rheumatoid arthritis and Crohn's disease, these therapies carry risks of serious infections and immunosuppression due to the inhibition of normal host defense mechanisms (StatPearls, 2023). The complexity of these pathways necessitates precise targeting to avoid broad systemic toxicity while achieving therapeutic efficacy.

Other names

Inflammatory cascadePro-inflammatory cytokine networkCytokine signaling pathwaysInflammatory signaling milieu

Inhibition of specific cytokine-receptor interactions or intracellular signal transduction enzymes (such as Janus kinases) to dampen the production and activity of inflammatory mediators.